📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. (2011)

First Author: Matsa E

Attributed to: A novel system for perfusion and real-time analysis of single hESC-derived cardiomyocytes funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehr073

PubMed Identifier: 21367833

Publication URI: http://europepmc.org/abstract/MED/21367833

Type: Journal Article/Review

Volume: 32

Parent Publication: European heart journal

Issue: 8

ISSN: 0195-668X